Your browser doesn't support javascript.
loading
Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Cell Transplantation Program, Part I: Minimum Requirements and Beyond.
Pasquini, Marcelo C; Srivastava, Alok; Ahmed, Syed Osman; Aljurf, Mahmoud; Atsuta, Yoshiko; Doleysh, Carol; Galeano, Sebastian; Gluckman, Eliane; Greinix, Hildegard; Hale, Gregory A; Hari, Parameswaran; Hashmi, Shahrukh K; Kamani, Naynesh; Laughlin, Mary J; Niederwieser, Dietger; Seber, Adriana; Szer, Jeffrey; Snowden, John A; Van Biesen, Koen; Watry, Paula; Weisdorf, Daniel J; Apperley, Jane.
Affiliation
  • Pasquini MC; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI. Electronic address: mpasquini@mcw.edu.
  • Srivastava A; Department of Hematology, Christian Medical College, Vellore, India.
  • Ahmed SO; Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Aljurf M; Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
  • Doleysh C; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
  • Galeano S; Unidad de Hematología, Hospital Británico, Montevideo, Uruguay.
  • Gluckman E; Hôpital Saint-Louis, Paris, France.
  • Greinix H; Bone Marrow Transplantation Unit, Department of Internal Medicine I, Medical University of Vienna, Vienna, Australia.
  • Hale GA; Department of Hematology/Oncology, Johns Hopkins All Children's Hospital, St. Petersburg, FL.
  • Hari P; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
  • Hashmi SK; Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Kamani N; Children's National Medical Center, Washington, DC.
  • Laughlin MJ; Medical Director, Cleveland Cord Blood Center, Cleveland, Ohio.
  • Niederwieser D; University of Leipzig, Leipzig, Germany.
  • Seber A; Hospital Samaritano, São Paolo, Brazil.
  • Szer J; Clinical Haematology at Peter MacCalluma Cancer Centre and the Royal Melbourne Hospital, Victoria, Australia.
  • Snowden JA; JAS Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
  • Van Biesen K; Weill Cornell Medical College, New York, New York.
  • Watry P; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
  • Weisdorf DJ; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, Minnesota.
  • Apperley J; Haematology Department, Imperial College, Hammersmith Hospital, London, United Kingdom.
Biol Blood Marrow Transplant ; 25(12): 2322-2329, 2019 12.
Article in En | MEDLINE | ID: mdl-31071457

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Societies, Medical / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning Type of study: Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2019 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Societies, Medical / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning Type of study: Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2019 Type: Article